Abstract
The formation of biofilms is critical for the successful and stable colonization of mucosal surfaces by microbes, which often build three-dimensional environments by exuding exopolysaccharides and other macromolecules such as proteins, lipids, and even DNA. It is not just bacteria, but fungi such as yeast, that form these adherent interacting communities. Historically, biofilms have been studied in the context of pathogenesis, but only recently it has been recognized that important relationships among members of host-associated microbiomes are maintained within the context of biofilms. Host immune responses impact biofilm formation in various ways; for example, it is likely that formation of stable biofilms by non-pathogens improves barrier defenses by not just filling available niche spaces but also by helping to ward off pathogens directly. Recently, it was found that soluble immune effector molecules such as immunoglobulin A (IgA) in mammals serve essential roles in modulating complex biofilm communities in ways that benefit the host. Additional lines of evidence from other secreted immune effectors, such as the variable region-containing chitin-binding proteins (VCBPs) in protochordates, now suggest that this phenomenon is much more widespread than previously recognized. The activity of these immune molecules also likely serves roles beyond those of simple defense strategies; rather, they may be improving the outcome of symbiotic interactions benefiting the host. Thus, traditional immune assays that are aimed at studying the function of secreted immune effectors, such as agglutination assays, should take into account the possibility that the first observation may not be the last if the microbes under study are not directly killed. Here, we describe a series of simple approaches to characterize biofilm formation when bacteria (or yeast) are cultured in the presence of a secreted immune effector. To model this approach, we use microbes isolated from the gut of Ciona robusta, each grown in the presence or absence of VCBPs. The approaches defined here are amenable to diverse model systems and their microbes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murthy AK et al (2011) Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation. PLoS One 6(2):e16847
Bollinger RR et al (2003) Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 109(4):580–587
Rogier EW, Frantz AL, Bruno ME, Kaetzel CS (2014) Secretory IgA is concentrated in the outer layer of colonic mucus along with gut bacteria. Pathogens 3(2):390–403
Palestrant D et al (2004) Microbial biofilms in the gut: visualization by electron microscopy and by acridine orange staining. Ultrastruct Pathol 28(1):23–27
Bollinger RR, Barbas AS, Bush EL, Lin SS, Parker W (2007) Biofilms in the normal human large bowel: fact rather than fiction. Gut 56(10):1481–1482
Kotze SH et al (2011) Spontaneous bacterial cell lysis and biofilm formation in the colon of the Cape Dune mole-rat and the laboratory rabbit. Appl Microbiol Biotechnol 90(5):1773–1783
Orndorff PE et al (2004) Immunoglobulin-mediated agglutination of and biofilm formation by Escherichia coli K-12 require the type 1 pilus fiber. Infect Immun 72(4):1929–1938
Bollinger RR et al (2006) Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol 43(4):378–387
Barbas AS et al (2009) Altering and assessing persistence of genetically modified E. coli MG1655 in the large bowel. Exp Biol Med (Maywood) 234(10):1174–1185
Donaldson GP et al (2018) Gut microbiota utilize immunoglobulin A for mucosal colonization. Science 360(6390):795–800
Thomas AD, Parker W (2010) Cultivation of epithelial-associated microbiota by the immune system. Future Microbiol 5(10):1483–1492
Dishaw LJ, Cannon JP, Litman GW, Parker W (2014) Immune-directed support of rich microbial communities in the gut has ancient roots. Dev Comp Immunol 47(1):36–51
Kelly C, Salinas I (2017) Under pressure: interactions between commensal microbiota and the teleost immune system. Front Immunol 8:559
Dishaw LJ et al (2016) Gut immunity in a protochordate involves a secreted immunoglobulin-type mediator binding host chitin and bacteria. Nat Commun 7:10617
Cannon JP, Haire RN, Litman GW (2002) Identification of diversified genes that contain immunoglobulin-like variable regions in a protochordate. Nat Immunol 3(12):1200–1207
Cannon JP, Haire RN, Schnitker N, Mueller MG, Litman GW (2004) Individual protochordates have unique immune-type receptor repertoires. Curr Biol 14(12):R465–R466
Dishaw LJ et al (2011) A role for variable region-containing chitin-binding proteins (VCBPs) in host gut-bacteria interactions. Proc Natl Acad Sci U S A 108(40):16747–16752
Liberti A et al (2014) Expression of Ciona intestinalis variable region-containing chitin-binding proteins during development of the gastrointestinal tract and their role in host-microbe interactions. PLoS One 9(5):e94984
Liberti A, Cannon JP, Litman GW, Dishaw LJ (2019) A soluble immune effector binds both fungi and bacteria via separate functional domains. Front Immunol 10:369
Leigh BA, Liberti A, Dishaw LJ (2016) Generation of germ-free Ciona intestinalis for studies of gut-microbe interactions. Front Microbiol 7:2092
Henson MW et al (2016) Artificial seawater media facilitate cultivating members of the microbial majority from the Gulf of Mexico. mSphere 1(2):e00028-16
Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173(2):697–703
Hao H et al (2016) Yersinia spp. identification using copy diversity in the chromosomal 16S rRNA gene sequence. PLoS One 11(1):e0147639
White TJ, Bruns T, Lee S, Taylor J (1990) Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols. In: A guide to methods and application. Academic Press Inc., New York, pp 315–322
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15(2):167–193
O’Toole G, Kaplan HB, Kolter R (2000) Biofilm formation as microbial development. Annu Rev Microbiol 54:49–79
Merritt JH, Kadouri DE, O’Toole GA (2005) Growing and analyzing static biofilms. Curr Protoc Microbiol Chapter 1:Unit 1B 1
Fischer M, Sawers RG (2013) A universally applicable and rapid method for measuring the growth of streptomyces and other filamentous microorganisms by methylene blue adsorption-desorption. Appl Environ Microbiol 79(14):4499–4502
Fischer M, Schmidt C, Falke D, Sawers RG (2012) Terminal reduction reactions of nitrate and sulfate assimilation in Streptomyces coelicolor A3(2): identification of genes encoding nitrite and sulfite reductases. Res Microbiol 163(5):340–348
Chandra J et al (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183(18):5385–5394
Hawser SP, Baillie GS, Douglas LJ (1998) Production of extracellular matrix by Candida albicans biofilms. J Med Microbiol 47(3):253–256
Morales-Soto N et al (2015) Preparation, imaging, and quantification of bacterial surface motility assays. J Vis Exp (98):52338
Segel LA, Chet I, Henis Y (1977) A simple quantitative assay for bacterial motility. J Gen Microbiol 98(2):329–337
Wolfe AJ, Berg HC (1989) Migration of bacteria in semisolid agar. Proc Natl Acad Sci U S A 86(18):6973–6977
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Liberti, A., Leigh, B.A., Graham, Z., Natarajan, O., Dishaw, L.J. (2022). A Role for Secreted Immune Effectors in Microbial Biofilm Formation Revealed by Simple In Vitro Assays. In: Rast, J., Buckley, K. (eds) Immune Receptors. Methods in Molecular Biology, vol 2421. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1944-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1944-5_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1943-8
Online ISBN: 978-1-0716-1944-5
eBook Packages: Springer Protocols